Cure Today8h
Better Understanding Genetic Mutations Influence in Cancer Care
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer ...
Cure Today6d
Minimal Residual Disease Testing’s Variability Across Cancer Types
Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...
Genomic Reference Materials and Controls Systems Market, 2025-2035 - Companies Set to Capitalize on Liquid Biopsy and MRD Testing Demand
The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...
Oncology Nurse Advisor1d
Sustained MRD Negativity Observed With Cilta-Cel
Patients who received cilta-cel had improvements in progression-free survival and overall survival if they had sustained a minimal residual disease-negative complete response or better for at least 1 ...
BizWest1d
Foresight Diagnostics expands Allogene partnership
Foresight Diagnostics Inc., a Boulder-based cancer diagnostics company that specialized in the development of ultra-sensitive minimal residual disease, or MRD, detection, recently expanded its ...
Business Wire1d
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cance ...
Medindia4d
Non-Invasive ctDNA Testing for Early Detection of Multiple Myeloma
Discover how ctDNA revolutionizes multiple myeloma monitoring, tracking disease progression, and improving personalized ...